Patents by Inventor Enrique Brandan

Enrique Brandan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230019602
    Abstract: The invention relates to methods and agents useful for treating motor neuron diseases (MNDs), in particular, amyotrophic lateral sclerosis (ALS). Methods and agents for treating various physiological and pathological conditions associated with motor neuron diseases are also provided.
    Type: Application
    Filed: March 7, 2022
    Publication date: January 19, 2023
    Applicant: FibroGen, Inc.
    Inventors: Enrique BRANDAN, David GONZALEZ
  • Patent number: 11299537
    Abstract: The invention relates to methods and agents useful for treating motor neuron diseases (MNDs), in particular, amyotrophic lateral sclerosis (ALS). Methods and agents for treating various physiological and pathological conditions associated with motor neuron diseases are also provided.
    Type: Grant
    Filed: December 6, 2016
    Date of Patent: April 12, 2022
    Assignee: FIBROGEN, INC.
    Inventors: Enrique Brandan, David Gonzalez
  • Publication number: 20190002547
    Abstract: The invention relates to methods and agents useful for treating motor neuron diseases (MNDs), in particular, amyotrophic lateral sclerosis (ALS). Methods and agents for treating various physiological and pathological conditions associated with motor neuron diseases are also provided.
    Type: Application
    Filed: December 6, 2016
    Publication date: January 3, 2019
    Applicant: FibroGen, Inc.
    Inventors: Enrique BRANDAN, David GONZALEZ
  • Publication number: 20140356374
    Abstract: The present invention relates to methods and agents useful for treating muscular dystrophy. Methods and agents for treating various physiological and pathological features associated with muscular dystrophy are also provided.
    Type: Application
    Filed: July 1, 2014
    Publication date: December 4, 2014
    Applicant: FibroGen, Inc.
    Inventors: Enrique Brandan, Roel Goldschmeding, Noellyn A. Oliver
  • Publication number: 20140271573
    Abstract: A method of treating a muscular dystrophy disease in a patient includes administering an effective amount of a botanical drug isolated from Andrographis paniculata in combination with cell therapy. The method improves skeletal muscle performance.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE
    Inventors: Enrique Brandan, Daniel Cabrera, Jaime GUTIERREZ, Gabriela Morales, Claudio CABELLO-VERRUGIO, Juan Hancke
  • Patent number: 8771692
    Abstract: The present invention relates to methods and agents useful for treating muscular dystrophy. Methods and agents for treating various physiological and pathological features associated with muscular dystrophy are also provided.
    Type: Grant
    Filed: July 2, 2010
    Date of Patent: July 8, 2014
    Assignee: FibroGen, Inc.
    Inventors: Enrique Brandan, Roel Goldschmeding, Noelynn A. Oliver
  • Publication number: 20120164151
    Abstract: The present invention relates to methods and agents useful for treating muscular dystrophy. Methods and agents for treating various physiological and pathological features associated with muscular dystrophy are also provided.
    Type: Application
    Filed: July 2, 2010
    Publication date: June 28, 2012
    Applicant: FibroGen, Inc.
    Inventors: Enrique Brandan, Roel Goldschmeding, Noel A. Oliver